Trial NCT04871529

View at ClinicalTrials.gov 
Org. Study IDs: S2011
Secondary IDs: NCI-2021-02265 S1905 U10CA180888

Last trial update was posted on 2023-08-15

MeSH Interventions

Antibodies, Monoclonal Avelumab Carboplatin Gemcitabine Immunoglobulin G Immunoglobulins

MeSH Conditions

Carcinoma Carcinoma, Transitional Cell Urinary Bladder Neoplasms

Other Conditions

Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall Infiltrating Renal Pelvis and Ureter Urothelial Carcinoma Stage II Bladder Cancer AJCC v8

Stopping Reasons

undergoing nrevision

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID